Goodbye Steglatro!11

anonymous

Guest
I can’t believe what I’m reading. Steglatro was supposed to be a Blockbuster drug. Best in class efficacy didn’t stand a chance with our Marketing team. It’s sad Merck couldn’t design a trial that showed some CV or CHF benefit. I guess Merck didn’t learn anything from ENHANCE!!!
 

<



I can’t believe what I’m reading. Steglatro was supposed to be a Blockbuster drug. Best in class efficacy didn’t stand a chance with our Marketing team. It’s sad Merck couldn’t design a trial that showed some CV or CHF benefit. I guess Merck didn’t learn anything from ENHANCE!!!


What do you mean, suppose to be a blockbuster?!?!? Steglatro is Merck's saving grace!!! Without it, what holds up Merck as a whole... Keytruda?!?!?!
 




Similar threads

Replies
18
Views
5K
Merck
anonymous
Replies
4
Views
2K
Merck
Anonymous
Replies
9
Views
2K
Merck
Anonymous
Replies
5
Views
3K
Merck
Anonymous